Investigational Drug Information for Tesofensine
What is the development status for investigational drug Tesofensine?
Tesofensine is an investigational drug.
There have been 13 clinical trials for Tesofensine.
The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2006.
The most common disease conditions in clinical trials are Obesity, Prader-Willi Syndrome, and Syndrome. The leading clinical trial sponsors are Saniona, NeuroSearch A/S, and Boehringer Ingelheim.
Summary for Tesofensine
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 2,115 |
| WIPO Patent Applications | 653 |
| Japanese Patent Applications | 54 |
| Clinical Trial Progress | Phase 2 (2006-09-01) |
| Vendors | 39 |
Recent Clinical Trials for Tesofensine
| Title | Sponsor | Phase |
|---|---|---|
| Study of Tesomet With Open-label Extension in Subjects With Prader-Willi Syndrome | Saniona | Phase 2 |
| Phase 2b Study of Tesomet With Open-label Extension in Subjects With Hypothalamic Obesity (HO) | Saniona | Phase 2 |
| 48 Weeks, Study to Evaluate Overall Safety and Tolerability of Co-administration of Tesofensine and Metoprolol in Subjects With Hypothalamic Injury-induced Obesity (HIO) | Saniona | Phase 2 |
Clinical Trial Summary for Tesofensine
Top disease conditions for Tesofensine
Top clinical trial sponsors for Tesofensine
US Patents for Tesofensine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
